论文部分内容阅读
目的探讨三维适形放疗(3DCRT)联合肝动脉化疗栓塞(TACE)治疗原发性肝癌的治疗效果和副反应。方法经病理学证实原发性肝癌24例,采用先行TACE,再行3DCRT,观察疗效及生存期。结果治疗后1、2年生存率分别为75.0%(18/24)和58.3%(14/24);局控率CR 3例(12.5%),PR17例(70.83%),NC 3例(12.5%),PD 1例(4.17%),总有效率(CR+PR)83.3%。主要的副反应为消化道症状及骨髓抑制。结论三维适形放疗联合肝动脉化疗栓塞术是非手术治疗原发性肝癌的有效治疗方案。
Objective To investigate the therapeutic effects and side effects of three-dimensional conformal radiotherapy (3DCRT) and transcatheter arterial chemoembolization (TACE) in the treatment of primary liver cancer. Methods 24 cases of primary hepatocellular carcinoma confirmed by pathology were treated with TACE first and then 3DCRT again to observe the curative effect and survival time. Results The 1-year and 2-year survival rates were 75.0% (18/24) and 58.3% (14/24) respectively after treatment. The rate of CR was 3 cases (12.5%), PR 17 cases (70.83%) and NC %), PD in 1 case (4.17%) and total effective rate (CR + PR) in 83.3%. The main side effects are gastrointestinal symptoms and myelosuppression. Conclusion Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization is an effective treatment for non-surgical treatment of primary liver cancer.